One Iron Street,
Boston , MA, 02210
Boston , MA, 02210
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in securities comprising the I More
Webiste
Directors
Dec 11, 2023- R. Charles Tschampion
- Ashley T. Rabun
- Teresa Polley
- Sheila Hartnett-Devlin
- Rory Tobin
- James Jessee
- Allison Grant Williams
- James E. Ross
Chief Compliance Officer
- Brian Harris
Price
- $ 134.89 ( -2.79 )
-
Apr 10, 2025Last Close
- Net Assets
-
$37.6B
Feb 27, 2024
- 52-Week High/Low
- $157.2 - $133
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-5.56%
5 Year
42.24%
Best
41.41%
2013
Worst
-23.31%
2008
Company Name |
Holding |
| Eli Lilly & Co | 13.43 % |
| UnitedHealth Group Inc | 8.71 % |
| Johnson & Johnson | 6.54 % |
| Merck & Co Inc | 5.83 % |
| AbbVie Inc | 5.63 % |
| Thermo Fisher Scientific Inc | 3.92 % |
| Abbott Laboratories | 3.36 % |
| Amgen Inc | 3.12 % |
| Danaher Corp | 3.06 % |
| Pfizer Inc | 2.95 % |
| More | 2.95 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XLV | 0% | 5.4% | 0.4% | -2.5% | 24.6% | 9.7% | 18.2% | 6.3% | 21.8% | -2.8% | |
| S&P 500 | -8.3% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 8.3% | -4.7% | -1.7% | 2.9% | -13% | 6.5% | -1.2% | 8.3% | -5.6% | ||||
| q2 | 0% | -2.5% | 2.5% | -6.4% | 9.5% | 13% | 0.3% | 5.3% | 7% | 6.2% | ||||
| q3 | 0% | 0% | -3% | -5.6% | 1.1% | 4.2% | -3.3% | 14.1% | 3.5% | 1% | ||||
| q4 | 0% | 0% | 6.1% | 12.2% | 10.7% | 7.2% | 13.1% | -9.1% | 0.6% | -4% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 2.9% | 3.2% | 2% | -5% | 3.3% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |